Skip to content

A Randomized Trial Evaluating EARLY Application of a Surfactant Dressing in Thermal Injury (EARLY)

A Randomized, Controlled Study Evaluating a Surfactant-based Wound Dressing for Tissue Salvage and Reduction in Surgical Burden

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04880655
Acronym
EARLY
Enrollment
27
Registered
2021-05-11
Start date
2021-08-03
Completion date
2023-10-24
Last updated
2023-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, Partial-thickness Burn

Keywords

EARLY, Randomized Clinical Trial, Surfactant, Dressing, Total Body Surface Area, Outcome Assessment, Thermal Burn Injuries

Brief summary

The purpose of this study is to test the following hypotheses: 1. Early use of water-soluble surfactant dressing (WSD) on partial-thickness burn wounds will result in tissue salvage and reduce surgical burden. 2. Early use of WSD on partial-thickness burn wounds will result in faster healing. 3. Use of WSD on partial-thickness burn wounds will result in less painful wound care. 4. Early use of WSD on partial-thickness burn wounds will result in less infection. 5. Early use of WSD on partial-thickness burn wounds will result in lower hospital costs.

Detailed description

Surfactant-based wound dressings have been utilized in chronic, non-healing wounds and small burn wounds to soften and aid removal of wound debris. In vitro data suggest enhanced healing properties are due the ability to stabilize and potentially reseal plasma membranes, thereby, retaining cellular integrity and enhance wound healing. Improved cellular viability and functionality has also been established in heat-shock, ionizing radiation, and electrical injury models. In one rat model, topically suffused mesentery demonstrated improved microvascular flow and reduction in the number of abnormally flowing microvessels following thermal injury. Intravenous administration has been studied in several disease states. In thermal injury, intravenous administration has shown potential to improve blood flow and reduce the zone of coagulation. Further, surfactant-based wound dressings are non-ionic and may facilitate removal, sensitize, or prevent bacterial biofilms. Biofilms are an evolved, protective mechanism bacteria utilize to reduce antimicrobial efficacy. Removal or penetration of biofilms is essential for bacterial eradication. There is little evidence demonstrating the efficacy of early use of a WSD for treating partial-thickness burn wounds.

Interventions

DEVICEWSD

Post debridement and within 24 hours of injury, wound care and WSD applied daily

DEVICEDressed with bacitracin and petrolatum gauze

Post debridement and within 24 hours of injury, wound care and dressing applied daily

Sponsors

Medline Industries
CollaboratorINDUSTRY
University of Tennessee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥ 18 years old * admitted within 24 hours of injury * partial-thickness burn wounds on at least two non-contiguous areas of \< 10% TBSA each and not involving face, fingers, toes, and perineum * initial management assessed to require inpatient care

Exclusion criteria

* chemical, electrical, or inhalation injury * pregnant * incarcerated * TBSA ≥ 20% * wound expected to heal within 7 days * patient or authorized representative unable or unwilling to consent * unable to consent within 24 hours of injury

Design outcomes

Primary

MeasureTime frameDescription
Percent difference (cm2) in partial-thickness wound conversionUp to 14 daysTissue salvage

Secondary

MeasureTime frameDescription
Time to 95% re-epithelializationUp to 28 daysHealing time
Daily pain scores for each wound care sessionUp to 7 daysPain via Numeric Rating Scale (0-10; 0 having no pain and 10 being the worst possible pain)
Incidence of burn wound infection and cellulitisUp to 28 daysInfection up to day of initial excision or day of discharge
Hospital costsUp to 28 daysCost of care during inpatient stay

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026